Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials
- PMID: 14754709
- DOI: 10.1097/01.AOG.0000107298.29343.6a
Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials
Abstract
Objective: Many women and clinicians believe that combination estrogen-progestin contraceptive use can lead to weight gain. This concern can deter women from starting hormonal contraception or lead to premature quitting. This review evaluated the association between combination contraceptive use and change in body weight.
Data sources: The computerized databases CENTRAL, MEDLINE, EMBASE, Popline, and LILACS (from their inception to 2002) were used to conduct this review. Known investigators and manufacturers were contacted for information about other trials not discovered in the database search.
Methods of study selection: All English-language, randomized controlled trials measuring weight change that were at least 3 treatment cycles in duration and that compared a combination contraceptive to a placebo or to a combination contraceptive that differed in drug, dosage, regimen, or study length were eligible for inclusion. Of the 570 reports of randomized controlled trials of eligible interventions that were identified, 42 trials were included in the systematic review.
Tabulation, integration, and results: Two reviewers independently abstracted data from the eligible trials using a standard form. Depending on the data available, the weighted mean difference using a fixed effect model with 95% confidence intervals was calculated for the mean change in weight between baseline and posttreatment measurements or the Peto odds ratio with 95% confidence intervals was calculated by using the proportion of women who gained or lost more than a specified amount of weight. The 3 placebo-controlled, randomized trials did not find evidence supporting a causal association between combination oral contraceptives or a combination skin patch and weight gain. Most comparisons from the 40 trials that compared 2 or more combination contraceptives showed no substantial difference in weight. In addition, discontinuation of combination contraceptives because of weight gain did not differ between groups when this factor was studied.
Conclusion: Available evidence is insufficient to determine the effect of combination contraceptives on weight, but no large effect is evident.
Similar articles
-
Combination contraceptives: effects on weight.Cochrane Database Syst Rev. 2003;(2):CD003987. doi: 10.1002/14651858.CD003998. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003987. doi: 10.1002/14651858.CD003987.pub2 Update in: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003998. doi: 10.1002/14651858.CD003998.pub2 PMID: 12804496 Updated. Review.
-
Combination contraceptives: effects on weight.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003987. doi: 10.1002/14651858.CD003987.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD003987. doi: 10.1002/14651858.CD003987.pub3 PMID: 16437470 Updated. Review.
-
Combination contraceptives: effects on weight.Cochrane Database Syst Rev. 2011 Sep 7;(9):CD003987. doi: 10.1002/14651858.CD003987.pub4. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2014 Jan 29;(1):CD003987. doi: 10.1002/14651858.CD003987.pub5 PMID: 21901687 Updated. Review.
-
Combination contraceptives: effects on weight.Cochrane Database Syst Rev. 2008 Oct 8;(4):CD003987. doi: 10.1002/14651858.CD003987.pub3. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2011 Sep 07;(9):CD003987. doi: 10.1002/14651858.CD003987.pub4 PMID: 18843652 Updated. Review.
-
Combination contraceptives: effects on weight.Cochrane Database Syst Rev. 2014 Jan 29;2014(1):CD003987. doi: 10.1002/14651858.CD003987.pub5. Cochrane Database Syst Rev. 2014. PMID: 24477630 Free PMC article. Review.
Cited by
-
Modern pharmacological treatment of obese patients.Ther Adv Endocrinol Metab. 2020 Jan 22;11:2042018819897527. doi: 10.1177/2042018819897527. eCollection 2020. Ther Adv Endocrinol Metab. 2020. PMID: 32030121 Free PMC article. Review.
-
Safety and efficacy of contraception--Why should the obese woman be any different?Rev Endocr Metab Disord. 2011 Jun;12(2):85-91. doi: 10.1007/s11154-011-9181-5. Rev Endocr Metab Disord. 2011. PMID: 21607613 Review.
-
Combined oral contraceptive use and obesity in women with polycystic ovary syndrome. A meta-analysis of randomized clinical trials.Arch Gynecol Obstet. 2024 Oct;310(4):2223-2233. doi: 10.1007/s00404-024-07637-5. Epub 2024 Jul 18. Arch Gynecol Obstet. 2024. PMID: 39026022
-
Clinical practice: Contraception in adolescents.Eur J Pediatr. 2012 Jun;171(6):895-9. doi: 10.1007/s00431-012-1676-x. Epub 2012 Feb 9. Eur J Pediatr. 2012. PMID: 22318432 Review.
-
Female sexual dysfunction.Int Urogynecol J Pelvic Floor Dysfunct. 2008 Feb;19(2):293-305. doi: 10.1007/s00192-007-0436-3. Epub 2007 Nov 1. Int Urogynecol J Pelvic Floor Dysfunct. 2008. PMID: 17973068 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials